Qosina Explains Expansion into the Bioprocess Market

Qosina offers an extensive selection of Oetiker® clamps that can be used in a wide range of applications where robust, secure connections are required. See our selection and also how to securely close the clamps

Human error is a determining factor in a large percentage of adverse events experienced in healthcare. Single-use bioprocessing is also vulnerable to human error, and while the consequences may not be as grave, this industry can learn from the medical device industry on proven techniques for error prevention. Using lessons learned and best practices, discover demonstrated error-proofing steps to eliminate risk or potential misconnections when designing single-use systems.

From the Qosina exhibit at Advanced Therapies Week 2022, Paul Priebe, Vice President of Business Development and New Markets discusses the strengths and deep knowledge that Qosina brings to the medical devices and bioprocessing industries and how it can be applied within the advanced therapies segment.

Learn about Qosina’s Irradiate to Order service for its single-use bioprocess components portfolio, which provides customers with a convenient way to purchase pre-irradiated bioprocess components. Learn more about Qosina’s Irradiate to Order service at https://www.qosina.com/irradiate-to-order